N2OFF, Inc. (NITO)
NASDAQ: NITO · Real-Time Price · USD
1.695
+0.015 (0.89%)
At close: Jan 9, 2026, 4:00 PM EST
1.719
+0.024 (1.40%)
After-hours: Jan 9, 2026, 7:53 PM EST
N2OFF Employees
As of December 31, 2024, N2OFF had 5 total employees, including 3 full-time and 2 part-time employees. The number of employees increased by 2 or 66.67% compared to the previous year.
Employees
5
Change (1Y)
2
Growth (1Y)
66.67%
Revenue / Employee
$41,800
Profits / Employee
-$1,329,200
Market Cap
4.60M
Employees Chart
Employees History
| Date | Employees | Change | Growth |
|---|---|---|---|
| Dec 31, 2024 | 5 | 2 | 66.67% |
| Dec 31, 2023 | 3 | -5 | -62.50% |
| Dec 31, 2022 | 8 | -2 | -20.00% |
| Dec 31, 2021 | 10 | 4 | 66.67% |
| Dec 31, 2020 | 6 | 0 | - |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2013 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2012 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2011 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Related Stocks
| Company Name | Employees |
|---|---|
| CRH plc | 79,800 |
| Linde | 65,289 |
| The Sherwin-Williams Company | 63,890 |
| Rio Tinto Group | 55,561 |
| Ecolab | 48,000 |
| BHP Group | 40,648 |
| Freeport-McMoRan | 28,500 |
| Newmont | 22,200 |
NITO News
- 6 days ago - N2OFF Advances $340,000 Payment to Gain Better Terms in Flag Solar Energy Initiative, Reflecting Approximately an Additional $1.7 Million in Project Profit Stake - GlobeNewsWire
- 13 days ago - N2OFF Accelerates European Renewable Energy Momentum with Major De-Risking Milestones and Approximately $1.69 Million Value Unlock in Germany and Italy - GlobeNewsWire
- 7 weeks ago - N2OFF: MitoCareX Identifies Hit Compounds and Targets Preclinical Candidate Nomination - GlobeNewsWire
- 2 months ago - N2OFF Completed Merger with Cancer Drug Discovery Company Targeting Tough-to-Treat Pancreatic and Lung Cancers - GlobeNewsWire
- 2 months ago - N2OFF Announces Closing of Merger with Drug Discovery Company Targeting Resistant Cancers Including Pancreatic and Non-Small Cell Lung Cancer - GlobeNewsWire
- 3 months ago - N2OFF Stockholders Approve Merger with Drug Discovery Company Targeting Resistant Cancers Including Pancreatic and Non-Small Cell Lung Cancer - GlobeNewsWire
- 4 months ago - N2OFF Provides Business Update on Successful Execution of Solar and Energy Storage Initiatives Across Europe - GlobeNewsWire
- 4 months ago - N2OFF to Expand its Melz Solar Project with Battery Storage - GlobeNewsWire